Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials11The opinions and assertions contained herein are the sole views of the author and should not be construed to reflect the views of the Department of the Navy or the Department of Defense.-Reference-Cited by-同舟云学术

Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials11The opinions and assertions contained herein are the sole views of the author and should not be construed to reflect the views of the Department of the Navy or the Department of Defense.

Published:1999-12 Issue:6 Volume:107 Page:48-54
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Schoenfeld Philip

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Meloxicam;Furst;Semin Arthritis Rheum,1997

2. Pharamacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2;Engelhardt;Br J Rheum,1996

3. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal insufficiency;Bevis;Br J Rheum,1996

4. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis;Huskisson;Br J Rheum,1996

5. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis;Reginster;Br J Rheum,1996

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost;JAAOS: Global Research and Reviews;2022-04

2. Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases;Modern Rheumatology Journal;2022-02-19

3. Crystallization of meloxicam in the presence of hydrophilic additives to tailor its physicochemical and pharmaceutical properties;Journal of Drug Delivery Science and Technology;2021-12

4. Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes;Archives of Pharmacal Research;2021-11-22

5. An old friend: 25 years of meloxicam use in Russia.;Rheumatology Science and Practice;2021-07-15